Nasacort (Triamcinolone Acetonide)

Triamcinolone Acetonide, the active ingredient in Nasacort, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis and nasal congestion in both adults and children by reducing inflammation of the nasal mucosa. The formulation meets EU regulatory standards and is produced under stringent quality‑assurance protocols.

GNH USA supplies Nasacort as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company provides reliable global logistics, ensuring product integrity throughout the supply chain with a focus on timely delivery and regulatory compliance.

Nasacort, a nasal corticosteroid, is used to manage inflammatory conditions of the nasal passages.

Allergic rhinitis: reduces nasal inflammation, relieving sneezing, itching, and runny nose. Seasonal allergic rhinitis: provides consistent symptom control during pollen seasons. Nasal congestion: decreases swelling of nasal tissues, improving airflow and reducing blockage.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Throat irritation - Altered taste perception

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Adrenal suppression with prolonged high‑dose use

Use Nasacort only as directed by a healthcare professional. Avoid prolonged continuous use without medical review. Monitor for signs of local infection or unusual nosebleeds. Caution in patients with glaucoma, cataracts, or uncontrolled diabetes. Age Restrictions: follow prescriber guidance for pediatric use. Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors: may raise local drug exposure. - Live vaccines: potential reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance sedation if combined with sedating agents. - Nasal decongestants: possible increased local irritation. - Antiviral nasal sprays: monitor for additive mucosal effects.